Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...

Pandemic fears: real and imagined

“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...

Jayant Bhandari | Hysteria Creates Opportunity

Jayant Bhandari the founder of Capitalism and Morality sits down with Maurice Jackson of Proven and Probable to discuss the coronavirus and its global impact. Jayant will discuss the inefficiency of government and his thoughts on who is to blame for the ...

Gold has immunity, silver has ratio

On Monday Wall Street pared back losses from last week’s sell-off, the worst since 2008, but it was only the promise of lowering interest rates, the return of the “punch bowl” hearkening back to recession-era stimulus, that has tempora...

Central Bank Folly: Blame the Boomers

"Destroyers seize gold and leave to its owners a counterfeit pile of paper." —Ayn Rand The baby-boom generation, of which I am a less-than-proud member, blew it. There was a time long, long ago when the mention of the words "baby boomer" evoked a sense of pride of me...

BioNTech, Gilead, Memphasys - modern science and COVID and IVF

People around the world are worried about the extent of the consequences associated with the spread of the corona virus COVID-19, and politicians and the economy are called upon to deal with the situation appropriately so that the loss of life and financial damage to the citiz...

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the...

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...

Gold Pulled Back, But Coronavirus Did Not

While viruses are counted among the simplest forms of life, they have quite a bearing on its advanced forms. And the coronavirus epidemic is, unfortunately, alive and well. What are the implications for the gold market? Coronavirus Infects Europe The coronavirus epidemi...

BioNTech, CureVac, Valeo Pharma - Growth after capital injection

Anyone working in the medical sector knows that the development of therapies and products usually costs a lot of time and especially a lot of money. In the race against the spread of the current Corona pandemic, there are major changes in the industry, because whoever comes to...
1 2 3 4 5 6 7 8 9 10